Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma-Reference-Cited by-同舟云学术

Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma

Published:2014-09-02 Issue:37 Volume:111 Page:13421-13426
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proc Natl Acad Sci USA

Author:

Robert Francis,Roman William,Bramoullé Alexandre,Fellmann Christof,Roulston Anne,Shustik Chaim,Porco John A.,Shore Gordon C.,Sebag Michael,Pelletier Jerry

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference37 articles.

1. Initial genome sequencing and analysis of multiple myeloma

2. Gertz MA Ghobrial I Luc-Harousseau J (2009) Multiple myeloma: Biology, standard therapy, and transplant therapy. Biol Blood Marrow Transplant 15(1, Suppl):46–52.

3. DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival

4. Emerging Therapeutics Targeting mRNA Translation

5. c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silvestrol, a potent anticancer agent with unfavourable pharmacokinetics: Current knowledge on its pharmacological properties and future directions for the development of novel drugs;Biomedicine & Pharmacotherapy;2024-08

2. Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy;Cell Communication and Signaling;2024-06-11

3. eIF4A1 is essential for reprogramming the translational landscape of Wnt-driven colorectal cancers;2023-11-13

4. The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2;PLOS ONE;2023-06-29

5. The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment;Nature Reviews Cancer;2023-05-04